A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine
Tsipas S, Khan T, Loustalot F, Myftari K, Wozniak G
Your condition may require ongoing monitoring or further treatment
The risk of dehydration and hypotension means that empagliflozin is not recommended in patients aged 85 years and over, and caution is advised in those aged over 75 years
In medical settings, dosing decisions depend on: Body weight and composition Insulin sensitivity Baseline IGF-1 levels Growth hormone axis function Medical history Risk factors for hypoglycemia Unlike standard supplements, IGF-1 is a potent signaling molecule that influences glucose metabolism and cellular proliferation
A reader who understands the actual structural problem can ask better questions of any unpatentable therapeutic, and tell promising-but-untrialled apart from suppressed-but-proven